Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Triterpenoids from Grewia plagiophylla K. Schumriterpenoids from Grewia plagiophylla K. Schum

    wadmin1By wadmin1July 1, 2020Updated:August 9, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Peter Muchoki Githinji1, Jeremiah Waweru Gathirwa2,*, Margret Mwihaki Ng’ang’a1, Alex King’ori Machocho1

    1Department of Chemistry, Kenyatta University, Nairobi, KENYA.

    2Kenya Medical Research Institute, Centre for Traditional Medicine and Drug Research, Nairobi, KENYA.

    Pharmacognosy Communications,2020,10,3,130-133.
    DOI:10.5530/pc.2020.3.25
    Published: July 2020
    Type: Original Article

    ABSTRACT

    Introduction: Plants of the genus Grewia have been used as medicinal agents to treat several diseases. Grewia species are reported in use as folk medicine for the treatment of malaria, diarrhoea, dysentery, typhoid fever, small pox, cough, irritable condition of intestine and bladder among others. Methods: The stem back material of Grewia plagiophylla was extracted using CH2Cl2: MeOH (1:1). Fractionation and Isolation of the extract was done using column chromatography with silica gel and eluting with hexaneethyl acetate solvent system in increasing polarity. The structures of the isolated compounds were elucidated on the basis of NMR experiments and the comparison of their spectroscopic data with literature values. Results: Studies on bioactive components of the stem back of Grewia plagiophylla led to isolation of three triterpenoids: stigmasterol (I), butelin (II) lup-20(29)-en-3-ol (III). The triterpenoids have been isolated for the first time from this species with compound (III) being reported for the first time from the genus of Grewia. The isolated compounds showed varying degrees of in vitro antimalarial activity against Plasmodium falciparum chloroquine-sensitive D6 and chloroquine-resistance W2 strains with significant cytotoxic activity against Vero cells.

    Key words: Anti-plasmodial, Compounds, cytotoxicity, Grewia plagiophylla, Triterpenoids.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up